Literature DB >> 12700465

Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy.

Bruce J Brew1, Steve Tisch, Matthew Law.   

Abstract

We prospectively assessed serum lactate and plasma HIV viral load in 20 patients with stavudine-related nucleoside neuropathy, 10 with HIV-related distal sensory polyneuropathy (DSPN), 20 receiving stavudine but without neuropathy and 23 not receiving stavudine and without neuropathy. Raised serum lactate levels discriminated between stavudine nucleoside neuropathy and DSPN with 90% sensitivity and 90% specificity (P = 0.001). DSPN occurred despite an undetectable viral load, making it a poor discriminator.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700465     DOI: 10.1097/00002030-200305020-00024

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

Review 1.  Advances in understanding drug-induced neuropathies.

Authors:  Amanda C Peltier; James W Russell
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Peripheral neuropathy in HIV: prevalence and risk factors.

Authors:  Scott R Evans; Ronald J Ellis; Huichao Chen; Tzu-min Yeh; Anthony J Lee; Giovanni Schifitto; Kunling Wu; Ronald J Bosch; Justin C McArthur; David M Simpson; David B Clifford
Journal:  AIDS       Date:  2011-04-24       Impact factor: 4.177

Review 3.  Neurological and psychiatric adverse effects of antiretroviral drugs.

Authors:  Michael S Abers; Wayne X Shandera; Joseph S Kass
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

4.  Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection.

Authors:  V Valcour; T-M Yeh; R Bartt; D Clifford; M Gerschenson; S R Evans; B A Cohen; G J Ebenezer; P Hauer; L Millar; M Gould; P Tran; C Shikuma; S Souza; J C McArthur
Journal:  HIV Med       Date:  2009-02       Impact factor: 3.180

5.  Peripheral neuropathy in patients with human immunodeficiency viral infection at a tertiary hospital in Ghana.

Authors:  Peter Puplampu; Vincent Ganu; Ernest Kenu; William Kudzi; Patrick Adjei; Leticia Grize; Michael Käser
Journal:  J Neurovirol       Date:  2019-04-26       Impact factor: 2.643

6.  Influence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathy.

Authors:  Olajumoke Oshinaike; Akinsegun Akinbami; Oluwadamilola Ojo; Anthonia Ogbera; Njideka Okubadejo; Frank Ojini; Mustapha Danesi
Journal:  AIDS Res Treat       Date:  2012-04-17

7.  A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain.

Authors:  Scott R Evans; David M Simpson; Douglas W Kitch; Agnes King; David B Clifford; Bruce A Cohen; Justin C McArthur
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.